Effect of sirolimus as an immunosuppressive agent on kidney transplantation in patients with diabetes mellitus; a systematic review
Introduction: Sirolimus is a macrolide and a type of immunosuppressant drug to prevent rejection of transplanted organs. This drug inhibits the activation of T and B lymphocytes and reduces the production of interleukin-2 (IL-2). Objectives: This study aimed to review the effect of sirolimus in kidn...
Saved in:
Main Authors: | Saeedeh Davar (Author), Mohsen Mohammad Rahimi (Author), Maasoumeh Mahdi Akhgar (Author), Sajjad Saei (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
by: Kirby Sean, et al.
Published: (2012) -
Immunosuppressive Drugs and Kidney Post-transplant Diabetes Mellitus
by: Ismael Bilal Ismael, et al.
Published: (2019) -
Autophagy in kidney transplants of sirolimus treated recipients
by: Sagar Bhayana, et al.
Published: (2017) -
Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
by: Foroutan N, et al.
Published: (2013) -
De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression
by: F. Friedersdorff, et al.
Published: (2010)